Virginia M Diavolitsis Selected Research

Platinum

1/2020

Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginia M Diavolitsis Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 02/2011
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Oropharyngeal Neoplasms 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Endometrial Neoplasms (Endometrial Cancer) 07/2011

Drug/Important Bio-Agent (IBA)

2	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2018
1	PlatinumIBA 01/2020
1	CreatinineIBA 02/2011

Therapy/Procedure

3	Radiotherapy 01/2020 - 02/2011
1	Salpingo-oophorectomy 07/2011
1	Hysterectomy 07/2011
1	Therapeutics 07/2011